Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol
Clinical trial NCT02337270 · COMPLETED
Trial details
- NCT number
- NCT02337270
- Sponsor
- McMaster University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2021-09-07
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.